Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 23 of 23 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/02/24
End: 04/30/24
Due: 04/30/25
Phase: N/A
Priority: Normal
Start: 11/15/20
End: 12/30/21
Due: 12/30/22
Phase: N/A
Priority: Normal
Start: 06/28/21
End: 08/09/21
Due: 08/09/22
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 09/24/22
Due: 09/24/23
Phase: N/A
Priority: Normal
Start: 05/15/22
End: 06/20/22
Due: 06/20/23
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 04/10/23
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 04/30/21
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 07/15/21
Due: 07/15/22
Phase: N/A
Priority: Normal
Start: 05/05/21
End: 07/08/21
Due: 07/08/22
Phase: N/A
Priority: Normal
Start: 04/04/22
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 04/01/21
End: 08/31/21
Due: 08/31/22
Phase: N/A
Priority: Normal
Start: 03/03/25
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 08/05/24
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 03/03/25
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 06/15/21
End: 10/27/21
Due: 10/27/22
The Effect of Virtual Exercises on Glycemic Control and Body Composition in Type 2 Diabetic Patients
Phase: N/A
Priority: Normal
Start: 07/28/23
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 07/04/22
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 06/20/22
End: 11/15/22
Due: 11/15/23
Phase: N/A
Priority: Normal
Start: 11/15/17
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: 07/04/22
End: 11/29/22
Due: 11/29/23
Phase: N/A
Priority: Normal
Start: 05/01/21
End: 07/15/21
Due: 07/15/22
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 06/30/16
Due: 06/30/17